site stats

Jeff marrazzo spark therapeutics

WebDec 17, 2024 · [CEO Council for Growth] Spark Therapeutics CEO and co-founder Jeff Marrazzo Spark Therapeutics, a member of the Roche Group, has unveiled plans for a $575 million gene therapy innovation... WebBut the needs of patients and families living with genetic diseases are immediate and vast,” said Jeffrey D. Marrazzo, chief executive officer of Spark Therapeutics. “With its worldwide reach and extensive resources, Roche will help us accelerate the development of more gene therapies for more patients for more diseases and further expedite ...

Jeffrey Marrazzo email address & phone number - RocketReach

WebDec 17, 2024 · “Through this significant investment and plans to more than double our physical footprint, we’re poised for continued growth as we seek to develop the next generation of genetic medicines as a member of the Roche Group,” said Jeff Marrazzo, chief executive officer and co-founder, of Spark Therapeutics. WebMar 8, 2024 · Spark Therapeutics, home of the biggest ever venture-backed exit in Philadelphia, will name a new chief executive officer, as its current and only CEO Jeffery … hillsborough county clerk of court hoover https://sportssai.com

Bret Marshall - Associate Director, Business Development and

WebVerve Therapeutics Jeff Marrazzo Co-founder and former CEO Spark Therapeutics Chi-Ting Huang Vice President CMC Pheon Therapeutics Samantha Truex CEO Upstream Bio Alicia J. Hager Chief Legal Officer Nkarta Hilary Malone CEO Certego Therapeutics Greg Naeve Chief Business Officer RootPath Genomics Catherine Stehman-Breen CEO Chroma Medicine WebFeb 23, 2024 · Jeffrey Marrazzo, CEO of gene therapy developer Spark Therapeutics, will step down as head of the company he co-founded almost nine years ago, steered to a historic Food and Drug Administration approval in 2024 and later led through a $4.3 billion buyout by Roche. Marrazzo will depart on April 1, Spark said Wednesday. The company was founded in 2013 by Katherine A. High, Jeffrey Marrazzo, and Steven Altschuler in an effort to commercially develop treatments against haemophilia that High was working on at Children's Hospital of Philadelphia. In January 2015, the company became a public company, trading under the ticker $ONCE via a $161 million initial public offering led by Chief Legal Officer Joseph La Barge. hillsborough county clerk locations

Spark Therapeutics Announces Departure of CEO and Founder Jeff Marrazzo …

Category:Spark Therapeutics CEO Jeff Marrazzo stepping down

Tags:Jeff marrazzo spark therapeutics

Jeff marrazzo spark therapeutics

Roche Future cures are in our genes

Web三个皮匠报告网每日会更新大量报告，包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新，通过行业分析栏目，大家可以快速找到各大行业分析研究报告等内容。 WebDec 17, 2024 · Jeff Marrazzo, Spark's CEO and cofounder, said the ability to invest in an expansion of this size is one reason why the company became excited about the prospect of being acquired by Roche several years ago.

Jeff marrazzo spark therapeutics

Did you know?

WebPresident & CEO – Global Blood Therapeutics Jeff Marrazzo Former Co-Founder and CEO Spark Therapeutics Jeff Marrazzo Former Co-Founder and CEO – Spark Therapeutics Cynthia Mazareas Partner WilmerHale Cynthia Mazareas Partner – WilmerHale Mark McClung EVP & Chief Business Officer Sangamo Mark McClung EVP & Chief Business … WebFeb 23, 2024 · Jeff Marrazzo, co-founder of Spark Therapeutics, will depart as the Philadelphia company's chief executive officer on April 1. Ron Philip, Spark's chief …

WebOct 5, 2024 · Jeff Marrazzo co-founded Spark Therapeutics in 2013 and has led the growth of the company from a research center within the Children’s Hospital of Philadelphia to a fully integrated, commercial gene therapy company. In this inaugural episode of Behind Biotech, we discussed: 1. How Jeff’s Philadelphia upbringing guides his commitment to ... WebFeb 23, 2024 · Under Jeff Marrazzo’s leadership, Spark launched world’s first FDA-approved gene therapy for a genetic disease. He also spearheaded Spark’s $4.8 billion acquisition …

WebOct 4, 2024 · CAMBRIDGE, Mass., Oct. 4, 2024 /PRNewswire/ -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing … WebDec 17, 2024 · “Through this significant investment and plans to more than double our physical footprint, we're poised for continued growth as we seek to develop the next generation of genetic medicines as a member of the Roche Group,” said Jeff Marrazzo, chief executive officer and co-founder, of Spark Therapeutics.

WebGet Jeffrey Marrazzo's email address (j*****@gmail.com) and phone number (917-838-....) at RocketReach. Get 5 free searches. ... Chief Executive Officer and Co-Founder @ Spark Therapeutics, Inc. Board Member @ Biotechnology Innovation Organization; see less Education. University of Pennsylvania - The Wharton School ...

WebFeb 10, 2024 · Jeff Marrazzo, the former CEO of Philadelphia-based Spark Therapeutics and a member of the innovation subcommittee of Gov. Josh Shapiro’s transition team, has several ideas on how Pennsylvania’s new governor can support the state’s innovation economy, particularly companies in biotechnology and life sciences, writes Harold … smart health scaleWebMar 5, 2024 · Roche’s gene therapy outfit Spark Therapeutics will get a fresh face April 1 as co-founding CEO Jeffrey Marrazzo steps down. Chief Operating Officer Ron Philip, a 10-year Pfizer veteran who joined Spark in 2024, will be Marrazzo’s successor. The FDA’s approval of retinal disease gene therapy Luxturna is likely to be the biggest part of… smart health regenceWebFeb 28, 2024 · "A decade ago, I had lunch with [former Spark CEO] Jeff Marrazzo when he was just getting Spark started and he was one of its three employees and I was beginning to plan our innovation... smart health qr code californiaWebSep 27, 2024 · View Jeffrey Marrazzo's email address (j*****@spark***.com) and phone number. Jeffrey works at Spark Therapeutics, Inc. as Chief Executive Officer and Co … hillsborough county clerk of court nhWebDec 17, 2024 · Jeffrey Marrazzo owns about 305,000 units of Spark Therapeutics, Inc common stock. In the last 4 years at Spark Therapeutics, Inc, Jeffrey Marrazzo has sold … smart health pulseWebDec 17, 2024 · Jeff Marrazzo admitted to mixed emotions Tuesday as Roche closed its $4.3 billion acquisition of Spark Therapeutics, the gene therapy company he co-founded and led as CEO for the past... hillsborough county classroom associationWebDec 17, 2024 · “Through this significant investment and plans to more than double our physical footprint, we're poised for continued growth as we seek to develop the next generation of genetic medicines as a member of the Roche Group,” said Jeff Marrazzo, chief executive officer and co-founder, of Spark Therapeutics. smart health products